查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571548

商业生物技术分离系统市场规模、份额、趋势分析报告：按方法、按应用、按地区、细分市场预测，2024-2030 年

Separation Systems For Commercial Biotechnology Market Size, Share & Trends Analysis Report By Method (Conventional Methods, Modern Methods), By Application (Pharmaceutical, Food & Cosmetics), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

商业生物技术分离系统市场成长与趋势：

Grand View Research, Inc. 的最新报告显示，全球商业生物技术分离系统市场预计到 2030 年将达到 405.5 亿美元，2024 年至 2030 年复合年增长率为 6.8%。

生物技术领域的深入研究以开发先进产品预计将推动未来几年的成长。此外，为了加速商业生产，该领域领先工业营业单位的贡献预计将推动市场。

政府机构为中小企业开发新技术提供资金。预计这将提高用于分离和精製生物分子的大规模上游生物製程系统的效率。此类设备广泛应用于食品和化妆品、农业、塑胶和化学产品的生产。

此外，技术先进的一次性生物製程系统在农产品加工、化学品和塑胶等各行业的普及也促进了上游加工产业的成长。患有慢性和严重代谢和遗传疾病的患者数量不断增加，最终增加了对潜在治疗药物的需求。对生物製药的需求不断增长可能会带来利润丰厚的成长。

此外，医疗改革的变化以及产业、政府和研究机构之间的公私合作预计将改善分离法的技术方面。因此，预计将在预测期内显着推动商业分离市场的成长。

商业生物技术分离系统市场报告亮点

  • 由于该领域的技术进步，传统分离技术预计将占据最大的收益占有率。
  • 然而，由于这些技术的采用越来越多，预计现代方法在未来几年将以最快的速度成长。
  • 产品性能的技术进步预计将推动商业生物技术分离系统市场的发展。
  • 由于治疗商业化系统的高利用率，製药业占据了最大的收益占有率。
  • 各种慢性病盛行率的上升间接支持了经济成长。
  • 北美由于充足的行政支持、广泛的研究和成熟的产业框架而在市场上占据主导地位。
  • 由于先进的工业化和政府的有利支持，预计亚太地区将在预测期内呈现最快的成长。
  • 私人公司与学术机构、私人公司和公共组织合作，加速产品开发并推出新系统。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章 商业生物技术分离系统的变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 商业生物技术分离系统市场分析工具
    • 波特的分析
    • PESTEL分析

第 4 章商业生物技术的分离系统：方法评估与趋势分析

  • 细分仪表板
  • 商业生物技术的分离系统：方法变异分析，2023 年和 2030 年
  • 传统方法
  • 现代方法

第五章商业生物技术的分离系统：应用评估与趋势分析

  • 细分仪表板
  • 商业生物技术分离系统：应用变化分析，2023 年和 2030 年
  • 製药
    • 疫苗
    • 蛋白质
    • 荷尔蒙/胰岛素
    • 酵素
    • 人血浆分馏
    • 哺乳动物细胞培养
  • 食品/化妆品
  • 农业
  • 其他的

第 6 章 商业生物技术的分离系统：区域估计与趋势分析

  • 2023 年和 2030 年商业生物技术分离系统的市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Thermo Fisher Scientific Inc.
    • QIAGEN
    • Horizon Discovery Ltd.
    • OriGene Technologies, Inc.
    • Oxford Biomedica PLC
    • SignaGen Laboratories
    • Flash Therapeutics
    • Takara Bio Inc.
    • Bio-Rad Laboratories, Inc.
    • System Biosciences, LLC.
    • Promega Corporation
    • F. Hoffmann-La Roche Ltd
    • Revvity
    • Catalent, Inc
简介目录
Product Code: GVR-2-68038-841-1

Separation Systems For Commercial Biotechnology Market Growth & Trends:

The global separation system for commercial biotechnology market size is expected to reach USD 40.55 billion by 2030, expanding at a CAGR of 6.8% from 2024 to 2030, according to a new report by Grand View Research, Inc. Intensive research in the field of biotechnology to develop advanced products is expected to boost growth in the coming years. Moreover, contributions of leading industrial entities in this sector for accelerating commercial production is anticipated to drive the market.

Government bodies are providing funds to small & medium enterprises for the development of novel technologies. This is expected to enhance the efficiency of large-scale upstream bioprocessing systems used for separation & purification of biomolecules. Such instruments are extensively used for the production of food & cosmetics, agriculture, plastics, and chemicals.

Moreover, the popularity of technologically advanced single-use bioprocessing systems in various industries, such as agro-processing, chemical & plastics is contributing toward the growth of the upstream processing sector. Rising cases of chronic & severe metabolic & genetic disorders are ultimately increasing the demand for potential therapeutics. Rising demand for biopharmaceuticals is likely to result in lucrative growth.

Furthermore, changing healthcare reforms and public-private collaborations among industrial players, government, and research institutions are expected to improve the technological aspects of separation methods. Thus, in turn, is anticipated to significantly render the growth of commercial separation market over the forecast period.

Separation Systems For Commercial Biotechnology Market Report Highlights:

  • Conventional separation techniques are estimated to account for the largest revenue share owing to technological advancements in the segment.
  • However, modern methods are anticipated to grow at the fastest pace in the coming years due to the rise in adoption of these technologies.
  • Technological advancements in product capabilities are anticipated to boost the separation systems for commercial biotechnology market.
  • Pharmaceutical industry accounted for the largest revenue share owing to higher usage of systems for commercialization of therapeutics.
  • Rising prevalence of various chronic disorders is indirectly boosting growth.
  • North America dominated the market with adequate administrative support, extensive research, and well-established industrial framework.
  • Asia Pacific region is expected to exhibit the fastest growth over the forecast period owing to progressive industrialization and favorable government support.
  • Companies are entering into collaborations with academic institutions, private, and public entities to accelerate product development and launch novel systems.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Separation Systems for Commercial Biotechnology Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Separation Systems for Commercial Biotechnology Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Separation Systems for Commercial Biotechnology Market: Method Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Separation Systems for Commercial Biotechnology Market: Method Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Conventional Methods
    • 4.3.1. Conventional Methods Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Chromatography
      • 4.3.2.1. Chromatography Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Flow Cytometry
      • 4.3.3.1. Flow Cytometry Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Membrane Filtration
      • 4.3.4.1. Membrane Filtration Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.5. Electrophoresis
      • 4.3.5.1. Electrophoresis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.6. Centrifugation
      • 4.3.6.1. Centrifugation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Modern Methods
    • 4.4.1. Modern Methods Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.2. Microarray
      • 4.4.2.1. Microarray Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.3. Lab-on-a-chip
      • 4.4.3.1. Lab-on-a-chip Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.4. Magnetic Separation
      • 4.4.4.1. Magnetic Separation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.4.5. Biochip
      • 4.4.5.1. Biochip Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Separation Systems for Commercial Biotechnology Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Separation Systems for Commercial Biotechnology Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Pharmaceutical
    • 5.3.1. Pharmaceutical Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.2. Vaccines
      • 5.3.2.1. Vaccines Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.3. Proteins
      • 5.3.3.1. Proteins Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.4. Hormones/Insulin
      • 5.3.4.1. Hormones/Insulin Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.5. Enzymes
      • 5.3.5.1. Enzymes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.6. Human Blood Plasma Fractionation
      • 5.3.6.1. Human Blood Plasma Fractionation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 5.3.7. Mammalian Cell Cultures
      • 5.3.7.1. Mammalian Cell Cultures Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Food & Cosmetics
    • 5.4.1. Food & Cosmetics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Agriculture
    • 5.5.1. Agriculture Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Separation Systems for Commercial Biotechnology Market: Regional Estimates & Trend Analysis

  • 6.1. Separation Systems for Commercial Biotechnology Market Share, By Region, 2023 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. South Korea
      • 6.4.6.1. South Korea Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Separation Systems for Commercial Biotechnology Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Thermo Fisher Scientific Inc.
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/Strategic Initiatives
    • 7.4.2. QIAGEN
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/Strategic Initiatives
    • 7.4.3. Horizon Discovery Ltd.
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/Strategic Initiatives
    • 7.4.4. OriGene Technologies, Inc.
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/Strategic Initiatives
    • 7.4.5. Oxford Biomedica PLC
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/Strategic Initiatives
    • 7.4.6. SignaGen Laboratories
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/Strategic Initiatives
    • 7.4.7. Flash Therapeutics
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/Strategic Initiatives
    • 7.4.8. Takara Bio Inc.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/Strategic Initiatives
    • 7.4.9. Bio-Rad Laboratories, Inc.
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/Strategic Initiatives
    • 7.4.10. System Biosciences, LLC.
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/Strategic Initiatives
    • 7.4.11. Promega Corporation
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/Strategic Initiatives
    • 7.4.12. F. Hoffmann-La Roche Ltd
      • 7.4.12.1. Participant's Overview
      • 7.4.12.2. Financial Performance
      • 7.4.12.3. Product Benchmarking
      • 7.4.12.4. Recent Developments/Strategic Initiatives
    • 7.4.13. Revvity
      • 7.4.13.1. Participant's Overview
      • 7.4.13.2. Financial Performance
      • 7.4.13.3. Product Benchmarking
      • 7.4.13.4. Recent Developments/Strategic Initiatives
    • 7.4.14. Catalent, Inc
      • 7.4.14.1. Participant's Overview
      • 7.4.14.2. Financial Performance
      • 7.4.14.3. Product Benchmarking
      • 7.4.14.4. Recent Developments/Strategic Initiatives